CTMG presents its Site Specific CRO Model, and two options for accelerated review of study data, to FDA GCP Roundtable

Anton Usala, MD, CTMG’s President and CEO, and members of the CTMG executive team were invited to meet with representatives of all three branches of the FDA (CDER, CBER, and CDRH), representatives from the FDA Commissioner’s Office on GCPs, FDA Enforcement, viagra sans ordonnance FDA veterinary medicine, and FDA Office of Scientific Research/Integrity to present […]